Ranjan Ravikant, Ahmed Anwar, Gourinath Samudrala, Sharma Pushkar
Eukaryotic Gene Expression Laboratory, National Institute of Immunology, New Delhi, India.
J Biol Chem. 2009 May 29;284(22):15267-76. doi: 10.1074/jbc.M900656200. Epub 2009 Mar 23.
Recent studies have demonstrated that calcium-dependent protein kinases (CDPKs) are used by calcium to regulate a variety of biological processes in the malaria parasite Plasmodium. CDPK4 has emerged as an important enzyme for parasite development, because its gene disruption in rodent parasite Plasmodium berghei causes major defects in sexual differentiation of the parasite ( Billker, O., Dechamps, S., Tewari, R., Wenig, G., Franke-Fayard, B., and Brinkmann, V. (2004) Cell 117, 503-514 ). Despite these findings, it is not very clear how PfCDPK4 or any other PfCDPK is regulated by calcium at the molecular level. We report the biochemical characterization and elucidation of molecular mechanisms involved in the regulation of PfCDPK4. PfCDPK4 was detected on gametocyte periphery, and its activity in the parasite was regulated by phospholipase C. Even though the Junction Domain (JD) of PfCDPK4 shares moderate sequence homology with that of the plant CDPKs, it plays a pivotal role in PfCDPK4 regulation as previously reported for some plant CDPKs. The regions of the J-domain involved in interaction with both the kinase domain and the calmodulin-like domain were mapped. We propose a model for PfCDPK regulation by calcium, which may also prove useful for design of inhibitors against PfCDPK4 and other members of the PfCDPK family.
最近的研究表明,钙依赖性蛋白激酶(CDPKs)可被钙离子用于调节疟原虫疟原虫中的多种生物学过程。CDPK4已成为寄生虫发育的一种重要酶,因为其在啮齿动物寄生虫伯氏疟原虫中的基因破坏会导致寄生虫的性别分化出现重大缺陷(Billker,O.,Dechamps,S.,Tewari,R.,Wenig,G.,Franke-Fayard,B.和Brinkmann,V.(2004年)《细胞》117,503-514)。尽管有这些发现,但目前尚不清楚PfCDPK4或任何其他PfCDPK在分子水平上是如何被钙调节的。我们报告了PfCDPK4调节所涉及的分子机制的生化特征和阐明。PfCDPK4在配子体周围被检测到,其在寄生虫中的活性受磷脂酶C调节。尽管PfCDPK4的连接结构域(JD)与植物CDPKs的连接结构域具有适度的序列同源性,但它在PfCDPK4调节中起关键作用,正如先前对一些植物CDPKs所报道的那样。绘制了J结构域中与激酶结构域和钙调蛋白样结构域相互作用的区域。我们提出了一种钙调节PfCDPK的模型,这也可能被证明对设计针对PfCDPK4和PfCDPK家族其他成员的抑制剂有用。